Molecular Biology of the Cell click for ASCB 2010 Annual Meeting page

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBoC in Press, 10.1091/mbc.E08-07-0762 on January 21, 2009

Vol. 20, Issue 6, 1606-1617, March 15, 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Materials
Right arrow All Versions of this Article:
E08-07-0762v1
20/6/1606    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakamoto, K.
Right arrow Articles by Tsuji, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakamoto, K.
Right arrow Articles by Tsuji, Y.

Role of the Tumor Suppressor PTEN in Antioxidant Responsive Element-mediated Transcription and Associated Histone Modifications

Kensuke Sakamoto*,{dagger}, Kenta Iwasaki*, Hiroyuki Sugiyama{dagger}, and Yoshiaki Tsuji*

*Department of Environmental and Molecular Toxicology, North Carolina State University, Raleigh, NC 27695; and {dagger}Graduate School of Systems Life Science, Kyushu University, Fukuoka 812-8581, Japan

Submitted July 25, 2008; Revised December 30, 2008; Accepted January 8, 2009
Monitoring Editor: M. Bishr Omary

Coordinated regulation of PI3-kinase (PI3K) and the tumor suppressor phosphatase and tensin homologue deleted on chromosome 10 (PTEN) plays a pivotal role in various cell functions. PTEN is deficient in many cancer cells, including Jurkat human leukemia. Here, we demonstrate that the status of PTEN determines cellular susceptibility to oxidative stress through antioxidant-responsive element (ARE)-mediated transcription of detoxification genes. We found that ferritin H transcription was robustly induced in tert-butylhydroquinone (t-BHQ)-treated Jurkat cells via an ARE, and it was due to PTEN deficiency. Chromatin immunoprecipitation assays revealed that p300/CREB-binding protein (CBP) histone acetyltransferases and Nrf2 recruitment to the ARE and Bach1 release were blocked by the PI3K inhibitor LY294002, along with the partial inhibition of Nrf2 nuclear accumulation. Furthermore, acetylations of histone H3 Lys9 and Lys18, and deacetylation of Lys14 were associated with the PI3K-dependent ARE activation. Consistently, PTEN restoration in Jurkat cells inhibited t-BHQ–mediated expression of ferritin H and another ARE-regulated gene NAD(P)H:quinone oxidoreductase 1. Conversely, PTEN knockdown in K562 cells enhanced the response to t-BHQ. The PTEN status under t-BHQ treatment affected hydrogen peroxide-mediated caspase-3 cleavage. The PI3K-dependent ferritin H induction was observed by treatment with other ARE-activating agents ethoxyquin and hemin. Collectively, the status of PTEN determines chromatin modifications leading to ARE activation.


This was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E08-07-0762) on January 21, 2009.

Address correspondence to: Yoshiaki Tsuji (yoshiaki_tsuji{at}ncsu.edu)

Abbreviations used: ARE, antioxidant-responsive element; CBP, CREB-binding protein; ChIP, chromatin immunoprecipitation; LDH, lactate dehydrogenase; NAC, N-acetyl cysteine; NQO1, NAD(P)H:quinone oxidoreductase 1; PI3K, phosphatidylinositol 3-kinase; PTEN, phosphatase and tensin homologue deleted on chromosome 10; ROS, reactive oxygen species; t-BHQ, tert-butylhydroquinone.




This article has been cited by other articles:


Home page
Toxicol SciHome page
P. M. Nguyen, M. S. Park, M. Chow, J. H. Chang, L. Wrischnik, and W. K. Chan
Benzo[a]pyrene Increases the Nrf2 Content by Downregulating the Keap1 Message
Toxicol. Sci., August 1, 2010; 116(2): 549 - 561.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. M. Costa, J. S. Smith, Y. Chen, J. Chen, H. S. Phillips, K. D. Aldape, G. Zardo, J. Nigro, C. D. James, J. Fridlyand, et al.
Reversing HOXA9 Oncogene Activation by PI3K Inhibition: Epigenetic Mechanism and Prognostic Significance in Human Glioblastoma
Cancer Res., January 15, 2010; 70(2): 453 - 462.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2009 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.